Drug intelligence / Profile preview

betamethasone dipropionate + clotrimazole + gentamicin

Development stage
Preclinical
Lead developer
Kaneka
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **topical combination drug** containing three active ingredients: - **Betamethasone dipropionate**: a potent synthetic glucocorticoid corticosteroid that inhibits the synthesis of inflammatory mediators such as prostaglandins, leukotrienes, and cytokines, reducing redness, swelling, itching, and local immune response. - **Clotrimazole**: an antifungal agent that inhibits fungal growth by damaging the permeability barrier in the fungal cytoplasmic membrane, primarily by inhibiting ergosterol synthesis. - **Gentamicin**: an aminoglycoside antibiotic that irreversibly binds bacterial 30S ribosomal subunits, inhibiting protein synthesis and thus killing or inhibiting the growth of susceptible bacteria. The combination is used for the **treatment of corticosteroid-responsive dermatoses complicated by secondary bacterial and/or fungal infections**, including inflamed cutaneous candidiasis, tinea, mixed infections, impetiginized eczema, and secondary infected dermatitis[1][2][3][4][6]. **Mechanism of action**: simultaneous anti-inflammatory, antifungal, and antibacterial activity at the site of application to treat mixed skin infections.

Brand names
GentrisoneQuadriderm NFQuadriderm AFAzonate GCTrizole GKezidermIfbQuododermSwissderm AFSKI DermDiprogen C
Other names
betamethasone + clotrimazole + gentamicinbetamethasone dipropionate/clotrimazole/gentamicin sulphate
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on betamethasone dipropionate + clotrimazole + gentamicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone dipropionate + clotrimazole + gentamicin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call